NOT-DA-10-022: Notice to Modify the Eligibility Information for PAR-10-173, NIDA Research Education Program for Clinical Researchers and Clinicians (R25)

Notice to Modify the Eligibility Information for PAR-10-173, NIDA Research Education Program for Clinical Researchers and Clinicians (R25)

Notice Number: NOT-DA-10-022

Key Dates
Release Date: July 9, 2010

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

Purpose

The purpose of this Notice is to modify Eligibility Information for participants of NIDA research education programs for clinical researchers and clinicians (R25), PAR-10-173.

Those in clinically focused career paths at the undergraduate level are eligible to participate, as long as the following two conditions are met:

The undergraduate students must be matriculated in a program leading to a baccalaureate degree, or be preparing for an early admission graduate program or dual degree research/clinical doctorate program (some of these programs may not require a baccalaureate degree for admission). Premedical students constitute an example of eligible undergraduates.
The undergraduate research education and training must be a complementary component of the overall proposed program and not the sole or primary component. The undergraduate program component should be well integrated with the overall program, and further the goals/objectives stated in the original Funding Opportunity Announcement (FOA).

Undergraduate students are allowed to receive salary and fringe benefits consistent with the institutional salary policies for employees in similar positions. Institutional rates for undergraduate salary should be no more than $10.00 per hour plus fringe benefits (only when such benefits are provided to other employees in similar positions).

This is a change from the original FOA, which did not include undergraduates among those eligible to participate—see Executive Summary, Section I, and Section III.3 of the FOA.

All other aspects of this FOA remain unchanged.

Inquiries

Inquiries regarding this Notice should be directed to:

Mimi M. Ghim, Ph.D.
Office of Science Policy and Communications
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Blvd., Room 5232
Bethesda, MD 20892-9591
Phone: 301-443-6071
Email: [email protected]